{"batchcomplete":"","continue":{"lecontinue":"20240415072837|682","continue":"-||"},"query":{"logevents":[{"logid":692,"ns":0,"title":"Marcadors moleculars i citogen\u00e8tics","pageid":422,"logpage":422,"revid":1813,"params":{},"type":"create","action":"create","user":"Jmescriba","timestamp":"2025-07-29T07:22:31Z","comment":"Es crea la p\u00e0gina amb \u00abEls biomarcadors tumorals son subst\u00e0ncies biol\u00f2giques (gens, ant\u00edgens oncofetals, enzims, hormones o prote\u00efnes, entre d\u2019altres), que poden estar elevades en pres\u00e8ncia d\u2019un c\u00e0ncer, b\u00e9 com a reacci\u00f3 del hoste davant del tumor o b\u00e9 com a producte del propi tumor. Aquestes subst\u00e0ncies son detectables en diferents fluids biol\u00f2gics o teixit tumoral. En general, degut a la manca d\u2019una elevada sensibilitat i especificat diagn\u00f2stiques, els marcadors tumo...\u00bb."},{"logid":691,"ns":6,"title":"Fitxer:Imagen1.jpg","pageid":421,"logpage":421,"revid":1799,"params":{},"type":"create","action":"create","user":"Jmescriba","timestamp":"2025-03-20T15:04:20Z","comment":""},{"logid":690,"ns":6,"title":"Fitxer:Imagen1.jpg","pageid":421,"logpage":421,"revid":1799,"params":{"img_sha1":"2k5uc2016xvkbw2f7tc7q99wxf9wd27","img_timestamp":"2025-03-20T15:04:20Z"},"type":"upload","action":"upload","user":"Jmescriba","timestamp":"2025-03-20T15:04:20Z","comment":""},{"logid":689,"ns":6,"title":"Fitxer:Taula 1- Puntuaci\u00f3 dels actors pron\u00f2stics inclosos en el c\u00e0lcul de l'IPSS-R.png","pageid":420,"logpage":420,"revid":1793,"params":{},"type":"create","action":"create","user":"Jmescriba","timestamp":"2025-03-20T13:59:50Z","comment":""},{"logid":688,"ns":6,"title":"Fitxer:Taula 1- Puntuaci\u00f3 dels actors pron\u00f2stics inclosos en el c\u00e0lcul de l'IPSS-R.png","pageid":420,"logpage":420,"revid":1793,"params":{"img_sha1":"henwdjlzq2zcyuvcdhirqjmd2bd7emz","img_timestamp":"2025-03-20T13:59:48Z"},"type":"upload","action":"upload","user":"Jmescriba","timestamp":"2025-03-20T13:59:48Z","comment":""},{"logid":687,"ns":0,"title":"Classificaci\u00f3 molecular (c\u00e0ncer endometrial)","pageid":419,"logpage":419,"revid":1751,"params":{},"type":"create","action":"create","user":"Jmescriba","timestamp":"2024-06-21T09:31:24Z","comment":"Es crea la p\u00e0gina amb \u00abEn la darrera d\u00e8cada, s\u2019ha demostrat que la classificaci\u00f3 tradicional del carcinoma d\u2019endometri (C54.X) no compleix per s\u00ed mateixa de manera objectiva la estratificaci\u00f3 del risc i s\u2019ha confirmat que la classificaci\u00f3 molecular del carcinoma endometrial es una eina m\u00e9s objectiva i confiable per a estratificar el risc d\u2019aquestes pacients. A m\u00e9s, aquesta era molecular ofereix la oportunitat de nous tractaments dirigits d\u2019acord a la mutaci\u00f3 o via mol...\u00bb."},{"logid":686,"ns":0,"title":"Infecci\u00f3 per H. PYLORI (Helicobacter pylory)","pageid":0,"logpage":416,"params":{},"type":"delete","action":"delete","user":"Jmescriba","timestamp":"2024-06-21T08:42:14Z","comment":"el contingut era: \u00abHelicobacter pylory (''H. pylori'') constitueix des dels primers anys 80 del segle passat l\u2019agent etiopatog\u00e8nic de malalties gastroduodenals com les \u00falceres p\u00e9ptiques, el c\u00e0ncer g\u00e0stric (CG) i el limfoma del teixit limfoide associat a mucosa (limfoma MALT). \u00a0El proc\u00e9s de carcinog\u00e8nesi g\u00e0strica es multifactorial i ''l\u2019H. pylori'', malgrat ser u...\u00bb, i l'\u00fanic col\u00b7laborador era \u00ab[[Special:Contributions/Jmescriba|Jmescriba]]\u00bb ([[User talk:Jmescriba|discussi\u00f3]])"},{"logid":685,"ns":0,"title":"Helicobacter pylori","pageid":418,"logpage":418,"revid":1745,"params":{},"type":"create","action":"create","user":"Jmescriba","timestamp":"2024-06-21T08:38:44Z","comment":"Es crea la p\u00e0gina amb \u00abHelicobacter pylory (''H. pylori'') constitueix des dels primers anys 80 del segle passat l\u2019agent etiopatog\u00e8nic de malalties gastroduodenals com les \u00falceres p\u00e9ptiques, el c\u00e0ncer g\u00e0stric (CG) i el limfoma del teixit limfoide associat a mucosa (limfoma MALT). \u00a0El proc\u00e9s de carcinog\u00e8nesi g\u00e0strica es multifactorial i ''l\u2019H. pylori'', malgrat ser un carcin\u00f2gen tipus I, no es l\u2019\u00fanic factor de risc per aquesta malaltia.  La infecci\u00f3 per H. Pylori causa...\u00bb."},{"logid":684,"ns":0,"title":"B (c\u00e0rrega tumoral en sang perif\u00e8rica)","pageid":417,"logpage":417,"revid":1731,"params":{},"type":"create","action":"create","user":"Jmescriba","timestamp":"2024-04-15T08:59:03Z","comment":"Es crea la p\u00e0gina amb \u00abAquesta variable s\u2019aplica en la micosis fungoide (9700.3) i en el s\u00edndrome de S\u00e9zary (M- M-9701.3).  * '''B<sub>0</sub> (molt baixa c\u00e0rrega tumoral)''': No es detecta malaltia en sang perif\u00e8rica o el recompte de c\u00e8l\u00b7lules tumoral \u00e9s molt baix. Aquesta condici\u00f3 s\u2019observa quan es detecten menys del 15% o menys de 250 c\u00e8l\u00b7lules/mm<sup>3\u00a0</sup> son: ** CD4+/CD26- \u00a0o ** CD4+/CD7-\u00a0 o ** altres limf\u00f2cits T anormals.  * '''B<sub>1</sub> (baixa c\u00e0rrega...\u00bb."},{"logid":683,"ns":0,"title":"Infecci\u00f3 per H. PYLORI (Helicobacter pylory)","pageid":0,"logpage":416,"revid":1725,"params":{},"type":"create","action":"create","user":"Jmescriba","timestamp":"2024-04-15T07:32:19Z","comment":"Es crea la p\u00e0gina amb \u00abHelicobacter pylory (''H. pylori'') constitueix des dels primers anys 80 del segle passat l\u2019agent etiopatog\u00e8nic de malalties gastroduodenals com les \u00falceres p\u00e9ptiques, el c\u00e0ncer g\u00e0stric (CG) i el limfoma del teixit limfoide associat a mucosa (limfoma MALT). \u00a0El proc\u00e9s de carcinog\u00e8nesi g\u00e0strica es multifactorial i ''l\u2019H. pylori'', malgrat ser un carcin\u00f2gen tipus I, no es l\u2019\u00fanic factor de risc per aquesta malaltia.  La infecci\u00f3 per H. Pylori causa...\u00bb."}]}}